EUVIMEDEUVIMED entdecken
Crossref

A Self−Augmenting Strategy of Glucose Starvation to Trigger Disulfidptosis for Enhanced Cancer Immunotherapy

Kai Song, Feiyu Zhao, Hongzhi Liu, Shan He, Mengfan Li, Minli Mo, Ye Fu, Rui Lu, Shuyun Zhou, Qing Yin, Shanyue Guan

Advanced Functional Materials · 2026-06 · 36 (49)

DOI: 10.1002/adfm.75894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 18.05.2026. Verfasst von Kai Song und 10 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose oxidase (GOx)−based therapy has emerged as a promising strategy for cancer treatment, yet its efficacy is constrained by limited active sites and suboptimal reaction kinetics. To address these challenges, we designed a ruthenium (Ru)–rhodium (Rh) alloy anchored on layered double hydroxide (denoted as RuRh@LDH) as an advanced nanozyme that concurrently mimics GOx‐ and catalase (CAT)−like activities. Unlike the traditional enzyme process, this RuRh@LDH initiates an alternative pathway by self−propelling catalytic cascade, where the O 2 produced by the CAT−like reaction directly fuels the GOx−like process, establishing an autocatalytic cycle that significantly enhances reaction kinetics, which was verified by the Density Functional Theory (DFT) calculations. As a result, RuRh@LDH exhibits exceptional catalytic efficiency attributable to the synergistic electronic interaction within the alloy structure and the dual heat and mass transfer pathways between adjacent catalytic sites. The self−sustaining reaction leads to rapid glucose depletion, disrupting both energy metabolism and redox homeostasis, and ultimately triggering disulfidptosis. Finally, RuRh@LDH suppressed tumor growth and promoted T cell infiltration, showing potent antitumor and immune‐activating effects. This work establishes a self‐accelerating alloy nanozyme, representing a paradigm shift in enzyme‐mimetic therapy for sustainable metabolic intervention in cancer.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Song, K., Zhao, F., Liu, H., He, S., Li, M., Mo, M., Fu, Y., Lu, R., Zhou, S., Yin, Q., & Guan, S. (2026). A Self−Augmenting Strategy of Glucose Starvation to Trigger Disulfidptosis for Enhanced Cancer Immunotherapy. Advanced Functional Materials, 36(49). https://doi.org/10.1002/adfm.75894

Vancouver

Song K, Zhao F, Liu H, He S, Li M, Mo M, et al. A Self−Augmenting Strategy of Glucose Starvation to Trigger Disulfidptosis for Enhanced Cancer Immunotherapy. Advanced Functional Materials. 2026;36(49). doi:10.1002/adfm.75894

BibTeX
@article{Song2026,
  author = {Song, Kai and Zhao, Feiyu and Liu, Hongzhi and He, Shan and Li, Mengfan and Mo, Minli and Fu, Ye and Lu, Rui and Zhou, Shuyun and Yin, Qing and Guan, Shanyue},
  title = {A Self−Augmenting Strategy of Glucose Starvation to Trigger Disulfidptosis for Enhanced Cancer Immunotherapy},
  journal = {Advanced Functional Materials},
  year = {2026},
  volume = {36},
  number = {49},
  doi = {10.1002/adfm.75894}
}
Kostenlos starten →